Cyclopol
PreclinicalSmall molecule
Cyclopol is one of 3 small molecule programs targeting Spine Surgery. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
3 competitors in Spine Surgery
#DrugCompanyPhaseTrials
1Zanaflex
LLegacy Health System
Phase 3
Bupivacaine Only
Pacira Pharmaceuticals, IncPreclinical
Cyclopol
BBeijing Tiantan Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Spine Surgery1 trial
Cyclopol on Electrophysiological Monitoring During Spine Surgery: a Randomized Controlled, Noninferiority Study
Unknown status·—·N/A·NCT05617690·148 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Cyclopol. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- BBeijing Tiantan Hospital